DrugPatentWatch Database Preview
GALLIUM CITRATE GA 67 Drug Profile
» See Plans and Pricing
Which patents cover Gallium Citrate Ga 67, and when can generic versions of Gallium Citrate Ga 67 launch?
Gallium Citrate Ga 67 is a drug marketed by Curium, Ge Healthcare, and Lantheus Medcl. and is included in three NDAs.
The generic ingredient in GALLIUM CITRATE GA 67 is gallium citrate ga-67. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gallium citrate ga-67 profile page.
Summary for GALLIUM CITRATE GA 67
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Suppliers / Packagers: | 2 |
| Clinical Trials: | 4 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | GALLIUM CITRATE GA 67 at DailyMed |
Recent Clinical Trials for GALLIUM CITRATE GA 67
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Aridis Pharmaceuticals, Inc. | Phase 1/Phase 2 |
| Radiological Society of North America | Phase 2 |
| Rutgers, The State University of New Jersey | Phase 2 |
US Patents and Regulatory Information for GALLIUM CITRATE GA 67
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Curium | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 018058-001 | Approved Prior to Jan 1, 1982 | BS | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Ge Healthcare | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 017700-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lantheus Medcl | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 017478-001 | Approved Prior to Jan 1, 1982 | BS | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
